Status unknownRelapsing and progressiveNCT06025903

We could not find results for this trial

I know where the results are

What it found

No result found

We found no results in the registry or in papers.

What it measured

Main measures

  • sequencing of mitochondrial DNA

    3 years

    Blood or spinal fluid markers

Who could take part

Relapsing and progressive · 18 and over

Inclusion Criteria: * Patients affected by primary progressive or relapsing remitting multiple sclerosis * Patient able to provide informed consent Exclusion Criteria: * Individuals with \< 18 years * Patients not affected by primary progressive or relapsing remitting multiple sclerosis

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The purpose of this project is to study genetic determinants of mitochondrial impairment in primary progressive multiple sclerosis. Specific aims are: 1) identify mitochondrial-related pathways, inherited and somatic mitochondrial DNA mutations associated to primary progressive multiple sclerosis, 2) functionally assess the identified genetic alterations.

Loading reviews and guidelines…

History

    1. Started

      Sept 2021

    2. Main results due

      Sept 2024

    3. Finished

      May 2025

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error